about
Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors.Structure-based virtual screening and identification of a novel androgen receptor antagonist.Discovery of Isoquinolinoquinazolinones as a Novel Class of Potent PPARγ Antagonists with Anti-adipogenic Effects.3-Arylisoquinolines as novel topoisomerase I inhibitors.Topoisomerase inhibitors as anticancer agents: a patent update.Pharmacological effects of berberine and its derivatives: a patent update.Design and synthesis of novel androgen receptor antagonists via molecular modeling.Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.Substituted 2-arylquinazolinones: Design, synthesis, and evaluation of cytotoxicity and inhibition of topoisomerases.Modification of 3-arylisoquinolines into 3,4-diarylisoquinolines and assessment of their cytotoxicity and topoisomerase inhibition.Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.Computer-aided discovery of aminopyridines as novel JAK2 inhibitors.SAR based design of nicotinamides as a novel class of androgen receptor antagonists for prostate cancer.Synthesis of benzo[3,4]azepino[1,2-b]isoquinolin-9-ones from 3-arylisoquinolines via ring closing metathesis and evaluation of topoisomerase I inhibitory activity, cytotoxicity and docking study.Design and synthesis of 4-amino-2-phenylquinazolines as novel topoisomerase I inhibitors with molecular modeling.Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase I inhibitors.Development of 3-aryl-1-isoquinolinamines as potent antitumor agents based on CoMFA.Synthesis, in vitro and in vivo evaluation of 3-arylisoquinolinamines as potent antitumor agents.Application of ring-closing metathesis for the synthesis of benzo[3,4]azepino[1,2-b]isoquinolin-9-ones
P50
Q33780313-8CAE2915-4DAB-466B-9CEC-3F74601893DEQ36216496-796FBA3E-B98B-4A4F-93B2-46CB2F51D548Q37303615-CC3603C2-2C77-4F7E-B9BD-91EDD955ED58Q37811444-D4C53178-0B3B-4EE6-A1E4-FA6059D9969BQ38101143-B848777F-702C-44CA-AE11-21D57058F59BQ38648635-72093F4E-94F5-4376-8F69-1659A816478FQ38802283-A3AA1866-F325-49A2-9469-184D7179BF2DQ38816189-7B8FFF0B-1722-44CB-87C7-DA7C545A7ECBQ38838428-DAD15D39-B149-46F2-BD9E-BFE3E43ECBFAQ38917390-1EEB2FBE-BC54-41D7-BA37-4A7DE671B4FFQ38987701-F980832C-D6A8-4AF1-8D24-BD2A9241D2CEQ39043401-5E7D19E7-644F-4018-B282-FCFA3B243D3EQ39175938-550162A6-B611-4613-98EA-B251206F4516Q39483300-16537A61-96C3-425D-B0DC-0EA6892C66F0Q39522276-B37853B8-CD6B-43DF-9C82-F1BA0ADB8D47Q39585777-2910976D-8C83-48C1-8DBD-7B1521D0D741Q39659470-1986CA8C-0531-4ED8-9D38-776FA8E91A7CQ53309727-A1C63F95-7358-4B80-B0E4-0B5EF26886E4Q84864361-8AD192DE-BD00-41BF-AE89-54C43953E15B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daulat Bikram Khadka
@ast
Daulat Bikram Khadka
@en
Daulat Bikram Khadka
@es
Daulat Bikram Khadka
@nl
Daulat Bikram Khadka
@sl
type
label
Daulat Bikram Khadka
@ast
Daulat Bikram Khadka
@en
Daulat Bikram Khadka
@es
Daulat Bikram Khadka
@nl
Daulat Bikram Khadka
@sl
prefLabel
Daulat Bikram Khadka
@ast
Daulat Bikram Khadka
@en
Daulat Bikram Khadka
@es
Daulat Bikram Khadka
@nl
Daulat Bikram Khadka
@sl
P106
P1153
35223460500
P31
P496
0000-0002-6634-5824